Room for improvement in ADR reporting

Australia needs to adopt a robust and standardised pharmacovigilance system to improve adverse drug reaction reporting, researchers believe. A review of reporting, monitoring and handling of ADRs in Australia, published in JMIR Public Health and Surveillance, found that “despite the existence of national and international guidelines for ADR reporting” there was “substantial interinstitutional variability” in